The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction

被引:17
|
作者
Di Martino, Mirko [1 ]
Kirchmayer, Ursula [1 ]
Agabiti, Nera [1 ]
Bauleo, Lisa [1 ]
Fusco, Danilo [1 ]
Perucci, Carlo Alberto
Davoli, Marina [1 ]
机构
[1] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy
来源
BMJ OPEN | 2015年 / 5卷 / 06期
关键词
MORTALITY;
D O I
10.1136/bmjopen-2015-007866
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Time-window bias was described in case-control studies and led to a biased estimate of drug effect. No studies have measured the impact of this bias on the assessment of the effect of medication adherence on health outcomes. Our goals were to estimate the association between adherence to drug therapies after myocardial infarction (MI) and the incidence of a new MI, and to quantify the error that would have been produced by a time-window bias. Setting: This is a population-based study. Data were obtained from the Regional Health Information Systems of the Lazio Region in Central Italy (around 5 million inhabitants). Participants: Patients discharged after MI in 2006-2007 were enrolled in the cohort and followed through 2009. Outcome measure: The study outcome was reinfarction: either mortality, or hospital admission for MI, whichever occurred first. Design: A nested case-control study was performed. Controls were selected using both time-dependent and time-independent sampling. Adherence to antiplatelets, a-blockers, ACE inhibitors/angiotensin receptor blockers (ACEI/ARBs) and statins was calculated using the proportion of days covered (PDC). Results: A total of 6880 patients were enrolled in the cohort. Using time-dependent sampling, a protective effect was detected for all study drugs. Conversely, using time-independent sampling, the beneficial effect was attenuated, as in the case of antiplatelet agents and statins, or completely masked, as in the case of ACEI/ARBs and a-blockers. For ACEI/ARBs, the time-dependent approach produced ORs of 0.83 (95% CI 0.57 to 1.21) and 0.72 (0.55 to 0.95), respectively, for '0.5<PDC <= 0.75' and 'PDC>0.75' versus '0 <= PDC <= 0.5'. Using the time-independent approach, the ORs were 0.96 (0.65 to 1.43) and 1.00 (0.76 to 1.33), respectively. Conclusions: A time-independent definition of a time-dependent exposure introduces a bias when the length of follow-up varies with the outcome. The persistence of time-related biases in peer-reviewed papers strongly suggests the need for increased awareness of this methodological pitfall.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] The Impact of Time-Window Bias on the Assessment of Long-Term Effect of Medication Adherence: The Case of Secondary Prevention after Myocardial Infarction
    Di Martino, Mirko
    Kirchmayer, Ursula
    Agabiti, Nera
    Bauleo, Lisa
    Fusco, Danilo
    Perucci, Carlo Alberto
    Davoli, Marina
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 580 - 580
  • [2] Long-term Medication Adherence after Myocardial Infarction: Experience of a Community
    Shah, Nilay D.
    Dunlay, Shannon M.
    Ting, Henry H.
    Montori, Victor M.
    Thomas, Randal J.
    Wagie, Amy E.
    Roger, Veronique L.
    AMERICAN JOURNAL OF MEDICINE, 2009, 122 (10): : 961.e7 - 961.e13
  • [3] Long-term adherence to evidence based secondary prevention therapies after acute myocardial infarction
    Akincigil, Ayse
    Bowblis, John R.
    Levin, Carrie
    Jan, Saira
    Patel, Minalkumar
    Crystal, Stephen
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 (02) : 115 - 121
  • [4] Long-Term Adherence to Evidence Based Secondary Prevention Therapies after Acute Myocardial Infarction
    Ayse Akincigil
    John R. Bowblis
    Carrie Levin
    Saira Jan
    Minalkumar Patel
    Stephen Crystal
    Journal of General Internal Medicine, 2008, 23 : 115 - 121
  • [5] Long-term secondary prevention of acute myocardial infarction, guidelines adherence and outcome
    Ergatoudes, C.
    Thunstrom, E.
    Rosengren, A.
    Bjorck, L.
    Bostrom, K. Bengtsson
    Falk, K.
    Fu, M.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1388 - 1389
  • [6] Kidney Function and Long-Term Medication Adherence after Myocardial Infarction in the Elderly
    Chang, Tara I.
    Desai, Manisha
    Solomon, Daniel H.
    Winkelmayer, Wolfgang C.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (04): : 864 - 869
  • [7] Summary of the recommendations for long-term secondary prevention after myocardial infarction
    Ostadal, Petr
    Taborsky, Milos
    Linhart, Ales
    Vrablik, Michal
    Ceska, Richard
    Cifkova, Renata
    Kralikova, Eva
    Adamkova, Vera
    Kvapil, Milan
    Jojko, Zorjan
    COR ET VASA, 2019, 61 (05) : 471 - 480
  • [8] Antiplatelet Therapy for Long-term Secondary Prevention After Myocardial Infarction
    Bonaca, Marc P.
    Sabatine, Marc S.
    JAMA CARDIOLOGY, 2016, 1 (06) : 627 - 628
  • [9] Long-term secondary prevention of acute myocardial infarction (SEPAT) – guidelines adherence and outcome
    Constantinos Ergatoudes
    Erik Thunström
    Annika Rosengren
    Lena Björck
    Kristina Bengtsson Boström
    Kristin Falk
    Michael Fu
    BMC Cardiovascular Disorders, 16
  • [10] Long-term secondary prevention of acute myocardial infarction (SEPAT) - guidelines adherence and outcome
    Ergatoudes, Constantinos
    Thunstrom, Erik
    Rosengren, Annika
    Bjorck, Lena
    Bostrom, Kristina Bengtsson
    Falk, Kristin
    Fu, Michael
    BMC CARDIOVASCULAR DISORDERS, 2016, 16